HEPLER, Douglas,DEMPSEY, Gail L.,JOHNSON, Roland,KELLY, Michael,DANIEL, Michael,PAULSEN, Neil E.,CLAYTON, Bert
申请号：
AU2018313933
公开号：
AU2018313933A1
申请日:
2018.08.09
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
